Monday, March 21, 2016

"I think one thing that came screaming through ...

... [in CMS's 2017 Draft Call Letter for Medicare Advantage and Part D Plans] is that they believe Part D definitely has a place in this opioid overutilization problem in the U.S. and that Part D plan sponsors should go the distance to help beneficiaries address that."

— Debra Devereaux, senior vice president of pharmacy services at Gorman Health Group, told AIS's Drug Benefit News.

No comments:

Post a Comment